Currently, there are 217.98M common shares owned by the public and among those 180.17M shares have been available to trade.
The company’s stock has a 5-day price change of -6.68% and 8.66% over the past three months. OSCR shares are trading -17.11% year to date (YTD), with the 12-month market performance down to -0.15% lower. It has a 12-month low price of $11.20 and touched a high of $23.79 over the same period. OSCR has an average intraday trading volume of 18.49 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -23.03%, -17.45%, and -12.56% respectively.
Institutional ownership of Oscar Health Inc (NYSE: OSCR) shares accounts for 62.11% of the company’s 217.98M shares outstanding.
It has a market capitalization of $3.42B and a beta (3y monthly) value of 1.88. The stock’s trailing 12-month PE ratio is 48.17, while the earnings-per-share (ttm) stands at $0.28. The company has a PEG of 0.33 and the debt-to-equity ratio at 0.22. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.64% over the week and 8.52% over the month.
Earnings per share for the fiscal year are expected to increase by 42.57%, and 205.02% over the next financial year.
Looking at the support for the OSCR, a number of firms have released research notes about the stock. UBS stated their Sell rating for the stock in a research note on July 15, 2025, with the firm’s price target at $11. Piper Sandler coverage for the Oscar Health Inc (OSCR) stock in a research note released on July 14, 2025 offered a Neutral rating with a price target of $14. Wells Fargo was of a view on July 11, 2025 that the stock is Underweight, while Barclays gave the stock Underweight rating on July 02, 2025, issuing a price target of $17. Raymond James on their part issued Mkt Perform rating on June 24, 2025.
